In AD, BDNF levels are reduced in the hippocampus and temporal cortex, and TrkB receptor expression is often downregulated or mislocalized, disrupting downstream ERK, PI3K/Akt, and cAMP response element-binding protein (CREB) pathways [8,33]. Here, CREB1 is linked to Alzheimer disease.